Subsequent downregulation of CAV-1 decreased the levels of p-PI3K, p-AKT, N-cadherin, and Vimentin proteins in glioma cells, while increasing E-cadherin proteins, without significant effects on the total levels of PI3K and AKT (Fig. 3D–F). The gene discussed is CAV1; the disease is central nervous system cancer.